|
🦁
|
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.
21 auth.
L. Yatham,
S. Kennedy,
S. Parikh,
A. Schaffer,
S. Beaulieu,
M. Alda,
C. O’Donovan,
G. MacQueen,
R. McIntyre,
Verinder Sharma,
...
A. Ravindran,
L. Young,
R. Milev,
D. Bond,
B. Frey,
B. Goldstein,
B. Lafer,
B. Birmaher,
Kyooseob Ha,
W. Nolen,
M. Berk
|
10 |
2013 |
10
🦁
|
|
🦁
|
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
29 auth.
L. Yatham,
S. Kennedy,
S. Parikh,
A. Schaffer,
D. Bond,
B. Frey,
Verinder Sharma,
B. Goldstein,
S. Rej,
S. Beaulieu,
M. Alda,
G. MacQueen,
R. Milev,
A. Ravindran,
C. O’Donovan,
...
D. Mcintosh,
R. Lam,
G. Vázquez,
F. Kapczinski,
R. McIntyre,
J. Kozicky,
S. Kanba,
B. Lafer,
T. Suppes,
J. Calabrese,
E. Vieta,
G. Malhi,
R. Post,
M. Berk
|
10 |
2018 |
10
🦁
|
|
🐜
|
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
10 auth.
C. Bowden,
J. Calabrese,
G. Sachs,
L. Yatham,
Shaheen Asghar,
M. Hompland,
...
P. Montgomery,
N. Earl,
T. Smoot,
J. Deveaugh-Geiss
|
9 |
2003 |
9
🐜
|
|
🦁
|
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.
19 auth.
L. Yatham,
S. Kennedy,
A. Schaffer,
S. Parikh,
S. Beaulieu,
C. O’Donovan,
G. MacQueen,
R. McIntyre,
Verinder Sharma,
A. Ravindran,
...
L. Young,
A. Young,
M. Alda,
R. Milev,
E. Vieta,
J. Calabrese,
M. Berk,
Kyooseob Ha,
F. Kapczinski
|
9 |
2009 |
9
🦁
|
|
🐜
|
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.
67 auth.
I. Pacchiarotti,
D. Bond,
R. Baldessarini,
W. Nolen,
H. Grunze,
R. Licht,
R. Post,
M. Berk,
G. Goodwin,
G. Sachs,
L. Tondo,
R. Findling,
E. Youngstrom,
M. Tohen,
J. Undurraga,
...
A. González-Pinto,
J. Goldberg,
A. Yıldız,
L. Altshuler,
J. Calabrese,
P. Mitchell,
M. Thase,
A. Koukopoulos,
F. Colom,
M. Frye,
G. Malhi,
K. Fountoulakis,
G. Vázquez,
R. Perlis,
T. Ketter,
F. Cassidy,
H. Akiskal,
J. Azorin,
M. Valentí,
D. H. Mazzei,
B. Lafer,
Tadafumi Kato,
L. Mazzarini,
A. Martínez-Àran,
G. Parker,
D. Souery,
A. Ozerdem,
S. McElroy,
P. Girardi,
M. Bauer,
L. Yatham,
C. Zarate,
A. Nierenberg,
B. Birmaher,
S. Kanba,
R. El-Mallakh,
A. Serretti,
Z. Rihmer,
A. Young,
G. Kotzalidis,
G. MacQueen,
C. Bowden,
S. Ghaemi,
C. López-Jaramillo,
J. Rybakowski,
Kyooseob Ha,
G. Perugi,
S. Kasper,
J. Amsterdam,
R. Hirschfeld,
F. Kapczinski,
E. Vieta
|
9 |
2013 |
9
🐜
|
|
🐢
|
Neuropsychological functioning in euthymic bipolar disorder: a meta‐analysis
I. Torres,
V. Boudreau,
V. Boudreau,
L. Yatham
|
9 |
2007 |
9
🐢
|
|
🐜
|
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
11 auth.
J. Calabrese,
C. Bowden,
G. Sachs,
L. Yatham,
K. Behnke,
O. Mehtonen,
...
P. Montgomery,
J. Ascher,
W. Paska,
N. Earl,
J. Deveaugh-Geiss
|
9 |
2003 |
9
🐜
|
|
🐢
|
Oxidative stress markers in bipolar disorder: a meta-analysis.
8 auth.
A. Andreazza,
A. Andreazza,
M. Kauer-Sant’Anna,
B. Frey,
D. Bond,
F. Kapczinski,
...
L. Young,
L. Yatham
|
8 |
2008 |
8
🐢
|
|
🦁
|
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
18 auth.
L. Yatham,
S. Kennedy,
C. O’Donovan,
S. Parikh,
G. MacQueen,
R. McIntyre,
Verinder Sharma,
P. Silverstone,
M. Alda,
P. Baruch,
...
S. Beaulieu,
A. Daigneault,
R. Milev,
L. Young,
A. Ravindran,
A. Schaffer,
M. Connolly,
C. Gorman
|
8 |
2005 |
8
🦁
|
|
🐜
|
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.
20 auth.
M. Tohen,
Mauricio Tohen,
E. Frank,
C. Bowden,
F. Colom,
S. Ghaemi,
L. Yatham,
G. Malhi,
J. Calabrese,
W. Nolen,
...
E. Vieta,
F. Kapczinski,
G. Goodwin,
T. Suppes,
G. Sachs,
K. Chengappa,
H. Grunze,
P. Mitchell,
S. Kanba,
M. Berk
|
8 |
2009 |
8
🐜
|
|
🐢
|
Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.
9 auth.
M. Kauer-Sant’Anna,
M. Kauer-Sant’Anna,
F. Kapczinski,
A. Andreazza,
A. Andreazza,
D. Bond,
...
R. Lam,
L. Young,
L. Yatham
|
8 |
2009 |
8
🐢
|
|
🐜
|
Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis.
10 auth.
Brisa Fernandes,
C. Gama,
K. Ceresér,
L. Yatham,
G. Fries,
G. Colpo,
...
D. D. de Lucena,
M. Kunz,
F. Gomes,
F. Kapczinski
|
8 |
2011 |
8
🐜
|
|
🐬
|
A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes
A. McGirr,
M. Berlim,
D. Bond,
M. Fleck,
L. Yatham,
R. Lam
|
8 |
2014 |
8
🐬
|
